Koios Signs Distribution and Sales Agreement with Wishing-U-Well

Cannabis Investing News
Cannabis Investing

Koios Beverage Corp. (CSE:KBEV; OTC:SNOVF) (the “Company” or “Koios”) is pleased to announce it has signed an agreement for ongoing sales and distribution of its products with Wishing-U-Well.

Koios Beverage Corp. (CSE:KBEV; OTC:SNOVF) (the “Company” or “Koios”) is pleased to announce it has signed an agreement for ongoing sales and distribution of its products with Wishing-U-Well.

Colorado-based distributor Wishing-U-Well is one of the largest retailers of health-based products on the Amazon online retail platform. The agreement is an extension of an existing sales agreement between the two companies, and confirms the ongoing relationship between Koios and one of its largest distributors.

“We are incredibly excited to be working with and renewing our distribution contract with Wishing-U-Well,” said Koios CEO Chris Miller. “They are one of Amazons largest and most trusted distribution partners. Having them in our corner makes our brand incredibly formidable on the world’s largest buying platform.”

Miller says the support provided by Wishing-U-Well is a vital part of the Company’s ongoing marketing and distribution due to its deep experience in online marketing and Amazon distribution.

“Wishing-U-Well employs over 100 people who are fully devoted to making sure the brands they represent stand out and sell,” Miller said. “Navigating Amazon with their help makes us competitive with any of the big brands we compete with, and gives us access to years’ worth of professional expertise in analytics, programming, branding, customer service, customer reviews, shipping, warehousing, and marketing.”

Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.

Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.

Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity.

On behalf of the Board of Directors of the Company.
Chris Miller, CEO and Director, KOIOS BEVERAGE CORP.

About Koios Beverage Inc.
The Company, through its wholly-owned subsidiary Koios, Inc., is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Together these distributors represent thousands of brick and mortar locations across the United States – from sports nutrition stores to large natural grocery chains including Whole Foods and Sunflower markets. Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product.
Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.mentaltitan.com/

Forward-Looking Statements
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding the timing for resumption of trading for the Company’s stock. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.

Source: www.newswire.ca

The Conversation (0)
×